Not checked for notices yet.
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma
Pearlman David S, Miller S David, LaForce Craig and 7 more
BMC Pulmonary Medicine · 2011
Cited by papers we hold 2
- Mast Cells and Their Progenitors in Allergic Asthma · 2019No notice
- Treatment of allergic asthma: Modulation of Th2 cells and their responses · 2011No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.